Description du projet
Une plateforme ouverte facilite la conception d’orthèses et de prothèses sur mesure imprimées en 3D
Le marché des orthèses et prothèses (O&P) sur mesure connait une croissance soutenue sous l’effet du vieillissement de la population et de l’augmentation des maladies comme les maladies vasculaires et le diabète. D’ici à 2027, une orthèse ou prothèse sur trois sera imprimée en 3D. L’objectif du projet OP-PLATFORM, financé par l’UE, est de démocratiser l’impression 3D pour tous les spécialistes de la médecine. Les chercheurs mettront au point une plateforme numérique révolutionnaire qui permettra aux cliniciens de concevoir des dispositifs de haute qualité adaptés à chaque patient et de les commander directement. L’équipe aura recours à l’IA, à l’apprentissage automatique et à des algorithmes avancés pour automatiser l’ensemble du processus de conception.
Objectif
Custom-made orthotic and prosthetic (O&P) market grows rapidly as the global population ages and suffers from civilisation diseases. In the next 10 years the O&P industry will be disrupted by digital economy (automatisation, 3D printing and 3D scanning). Due to rising costs of O&P products and patients’ demand for improved comfort, function and aesthetics, every third O&P product will be 3D printed by 2027. However 3DP products need to be custom designed and that is costly, know-how & time demanding. With our proprietary technology and 25 years experience in the O&P market, Invent Medical set to become the Uber in orthotics and seize this market share with the Open Digital Platform by leveraging 3rd parties and automating & democratising the whole process in an ultra scalable and affordable way. We are offering benefits of digitalisation to medical facilities to improve people’s life worldwide as custom-made orthoses and prostheses are the only effective solution in a treatment of difficult injuries, deficiencies and civilisation diseases.
The goal of Phase 1 of the project is to assess the feasibility of the Open Digital Platform business model. Activities will be focused on advanced Market analysis, IP research, Licensing of products, a Business Plan preparation and Pilot tests. Pilot testing of the platform will be conducted on two product lines to verify viability of the platform and cooperation with 3rd parties providing sales & support, manufacturing and computing. The project will have an impact on the global market due to global availability of a new generation of 3DP O&P products. Our disruptive business model complies with the EU strategy in healthcare to promote good health and healthy ageing by developing innovative solutions.
Champ scientifique
Programme(s)
Régime de financement
SME-1 - SME instrument phase 1Coordinateur
708 00 OSTRAVA
Tchéquie
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.